
Maury A. Audet
Examiner (ID: 761)
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675, 1658 |
| Total Applications | 1576 |
| Issued Applications | 696 |
| Pending Applications | 264 |
| Abandoned Applications | 656 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17140214
[patent_doc_number] => 20210308225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Long-Acting Formulations of Insulin
[patent_app_type] => utility
[patent_app_number] => 17/176442
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176442 | Long-Acting Formulations of Insulin | Feb 15, 2021 | Abandoned |
Array
(
[id] => 19624155
[patent_doc_number] => 12162959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Cyclic peptide for treating cancer
[patent_app_type] => utility
[patent_app_number] => 17/176983
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 4830
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176983 | Cyclic peptide for treating cancer | Feb 15, 2021 | Issued |
Array
(
[id] => 16977629
[patent_doc_number] => 20210221866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/169833
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169833 | PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS | Feb 7, 2021 | Abandoned |
Array
(
[id] => 16855173
[patent_doc_number] => 20210155918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => RECOMBINANT PROTHROMBIN ANALOGUES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/157130
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/157130 | Recombinant prothrombin analogues and uses thereof | Jan 24, 2021 | Issued |
Array
(
[id] => 17096894
[patent_doc_number] => 20210284685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS FOR REMOVING A CONTAMINANT USING INDIGENOUS PROTEIN DISPLACEMENT ION EXCHANGE MEMBRANE CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 17/153826
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153826
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153826 | METHODS FOR REMOVING A CONTAMINANT USING INDIGENOUS PROTEIN DISPLACEMENT ION EXCHANGE MEMBRANE CHROMATOGRAPHY | Jan 19, 2021 | Pending |
Array
(
[id] => 16839565
[patent_doc_number] => 20210147577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Mutated Immunoglobulin-Binding Polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/149830
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149830
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/149830 | Mutated immunoglobulin-binding polypeptides | Jan 14, 2021 | Issued |
Array
(
[id] => 16807845
[patent_doc_number] => 20210130398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/145231
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145231 | PROTEIN PURIFICATION | Jan 7, 2021 | Abandoned |
Array
(
[id] => 16885376
[patent_doc_number] => 20210171571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/145235
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145235 | PROTEIN PURIFICATION | Jan 7, 2021 | Abandoned |
Array
(
[id] => 16807846
[patent_doc_number] => 20210130399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PROTEIN PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/145233
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145233 | PROTEIN PURIFICATION | Jan 7, 2021 | Abandoned |
Array
(
[id] => 16948144
[patent_doc_number] => 20210206835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Self-Assembling Collagen-Like Polypeptides for Applications and Uses Related Thereto
[patent_app_type] => utility
[patent_app_number] => 17/140449
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140449 | Self-assembling collagen-like polypeptides for applications and uses related thereto | Jan 3, 2021 | Issued |
Array
(
[id] => 16915837
[patent_doc_number] => 20210188929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Peptides and Nanoparticle Formulations Thereof
[patent_app_type] => utility
[patent_app_number] => 17/134977
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/134977 | Peptides and nanoparticle formulations thereof | Dec 27, 2020 | Issued |
Array
(
[id] => 18575499
[patent_doc_number] => 11732013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Astexin peptides
[patent_app_type] => utility
[patent_app_number] => 17/128632
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 20572
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128632 | Astexin peptides | Dec 20, 2020 | Issued |
Array
(
[id] => 16748763
[patent_doc_number] => 20210100772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA
[patent_app_type] => utility
[patent_app_number] => 17/124572
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/124572 | METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA | Dec 16, 2020 | Abandoned |
Array
(
[id] => 16824256
[patent_doc_number] => 20210139549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/119786
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 127867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 445
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119786 | COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF | Dec 10, 2020 | Pending |
Array
(
[id] => 16824248
[patent_doc_number] => 20210139541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/119495
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119495 | COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF | Dec 10, 2020 | Pending |
Array
(
[id] => 19256872
[patent_doc_number] => 12016901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Tissue catalyzed growth of polymer as epithelial linings for therapy
[patent_app_type] => utility
[patent_app_number] => 17/118521
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 101
[patent_no_of_words] => 30315
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/118521 | Tissue catalyzed growth of polymer as epithelial linings for therapy | Dec 9, 2020 | Issued |
Array
(
[id] => 16762358
[patent_doc_number] => 20210107939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ANTIMICROBIAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/116054
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116054
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116054 | Antimicrobial compounds | Dec 8, 2020 | Issued |
Array
(
[id] => 17641941
[patent_doc_number] => 20220169679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => NOVEL ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/109056
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/109056 | Angiotensin I-converting enzyme (ACE) inhibitory peptides | Nov 30, 2020 | Issued |
Array
(
[id] => 16710443
[patent_doc_number] => 20210077590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK
[patent_app_type] => utility
[patent_app_number] => 17/104734
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104734
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104734 | METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK | Nov 24, 2020 | Abandoned |
Array
(
[id] => 16868533
[patent_doc_number] => 20210162000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/095992
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095992
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/095992 | PCSK9 inhibitory polypolypeptides and methods of use | Nov 11, 2020 | Issued |